APUS Apimeds Pharmaceuticals US, Inc.
T1 · DIRECT HOLDER confidence · Medium
The path
APUS ─ 1 004.84 BTC / 1 509 118 sh
─▶ 66 585 sats
Sats per share, split-adjusted
meanwhile: BTC held 1 005 BTC ▲
Export this chart as PNG — the watermark carries the vintage; screenshots without dates lie.
Split adjustment factors (raw numbers reconstruct: raw = adjusted ÷ factor)
| Effective | Ratio | Filing |
|---|---|---|
| 2026-07-24 | 1:10 | 8-K |
Vintage
Every figure above is only as current as its oldest contributing input: 2026-06-30 here . Positions and balances may have changed since. Sats per share moves on filings, not on price.
Market data TradingView
price panel unavailable for this ticker
third-party price data · outside the vintage system
Sources
- 10-Q · filed 2026-08-14 — 1 004.84 BTC as of 2026-06-30
Notes from the filings
What the filings disclose beyond the numbers — caveats, corporate actions, and composition details recorded at extraction. These qualify the figures above.
- CUSIP is the post-split number stated in the 2026-07-13 8-K ('The new CUSIP number for the Company's common stock following the Reverse Stock Split will be 037******', effective 12:01 a.m. ET 2026-07-24); the latest Schedule 13D/A (2026-05-07) shows pre-split CUSIP 03771D102.
- 747,702 preferred shares outstanding are excluded from the common count; the balance sheet also shows 3,636,262 'Common Shares to be issued' (not yet issued).
- BTC acquired via 2025-12-01 MindWave acquisition; also holds 639.1M NILA tokens and USDT; digital assets were 89% of total assets at 2026-06-30.
- [holdings 2026-06-30] BTC acquired via 2025-12-01 MindWave acquisition; also holds 639.1M NILA tokens and USDT; digital assets were 89% of total assets at 2026-06-30.